| 标题 |
Improving the Somatostatin Receptor Status Assessment for Personalized and Precise Management of Neuroendocrine Neoplasms with the Use of a 99m Tc-Radiolabeled Somatostatin Receptor Antagonist: The Final Results of the ERA PerMed TECANT Clinical Trial |
| 网址 | |
| DOI |
10.2967/jnumed.125.270347
doi
|
| 其它 |
期刊:Journal of Nuclear Medicine 作者:Alicja Hubalewska-Dydejczyk; Clemens Decristoforo; Renata Mikolajczak; Petra Kolenc; Marta Opalinska; et al 出版日期:2026-03-26 |
| 求助人 | |
| 下载 | 暂无链接,等待应助者上传 |
PDF的下载单位、IP信息已删除
(2025-6-4)